Form 4: Ionis Pharmaceuticals Director Buys Shares
Insider Transaction (Form 4)
Michael R Hayden, a Director of Ionis Pharmaceuticals Inc, purchased 20,000 shares of common stock on July 30, 2026.
Summary
- Open-market purchase: acquired 15,000 Common Stock at $53.38 ($800,700) on July 30, 2026; holds 19,000 after (Indirect).
- Open-market purchase: acquired 5,000 Common Stock at $51.60 ($258,000) on July 31, 2026; holds 24,000 after (Indirect).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $1,058,700, committing personal capital to the stock.
Insider Transactions
Michael R Hayden — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-30 | Open-market purchase | Common Stock | 15,000 | $53 | $800.7K | 19,000 |
| 2026-07-31 | Open-market purchase | Common Stock | 5,000 | $52 | $258.0K | 24,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-30 | Open-market purchase (15,000 shares) |
| 2026-07-31 | Open-market purchase (5,000 shares) |
Keywords
insider transaction, Form 4, IONS, IONIS PHARMACEUTICALS INC, bullish, Michael R Hayden
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.